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Abstract
Background
Ambulatory care-sensitive conditions, including asthma, can be managed with timely and
effective outpatient care, thereby reducing the need for hospitalization.
Objective
This study assessed the relationship between market competition, continuity of care (COC),
and hospital admissions in asthmatic children according to their health care provider.
Methods
A longitudinal design was employed with a 5-year follow-up period, between 2009 and
2013, under a Korean universal health insurance program. A total of 253 geographical
regions were included in the analysis, according to data from the Korean Statistical Office.
Data from 9,997 patients, aged 12 years, were included. We measured the COC over a
5-year period using the Usual Provider Continuity (UPC) index. Random intercept models
were calculated to assess the temporal and multilevel relationship between market competi-
tion, COC, and hospital admission rate.
Results
Of the 9,997 patients, 243 (2.4%) were admitted to the hospital in 2009. In the multilevel
regression analysis, as the Herfindahl–Hirschman Index increased by 1,000 points
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(denoting decreased competitiveness), UPC scores also increased (ß = 0.001; p < 0.0001).
In multilevel logistic regression analysis, the adjusted odds ratio (OR) for hospital admis-
sions for individuals with lower COC scores ( 2 ambulatory visits and a UPC index score
of < 1) was 3.61 (95% CI: 2.98–4.38) relative to the reference group ( 2 ambulatory visits
and a UPC index score of 1).
Conclusions
Market competition appears to reduce COC; decreased COC was associated with a higher
OR for hospital admissions.
Introduction
Ambulatory care-sensitive conditions (ACSCs), such as asthma, diabetes, hypertension,
chronic heart failure, and chronic obstructive pulmonary disease, can be managed with timely
and effective outpatient care, thereby reducing the need for hospitalization [1]. In particular,
the prevalence of asthma among pediatric patients remains high in adulthood, unlike certain
other chronic diseases. The socioeconomic cost of asthma, due to direct medical costs and indi-
rect costs (work and school absences) was 4 trillion Won in 2004 [2]. In 2011, the hospitaliza-
tion rate in Korea for patients with uncontrolled asthma was 102 per 100,000 population, more
than two-fold the Organization for Economic Cooperation and Development (OECD) average
of 52 per 100,000 population ([3]. Respiratory disease, including asthma, was the sixth leading
cause of death in 2012, according to the National Statistics Office [4].
Policymakers worldwide are beginning to recognize the magnitude of the problem of effi-
ciently managing chronic diseases with limited resources. High continuity of care (COC)
should be provided to reduce the risk of complications [5], improve preventive care [6,7],
increase patient satisfaction [8] and compliance [9,10], and decrease the requirement for emer-
gency and inpatient medical services [11–16]. Particularly in primary care, COC is being intro-
duced to improve care quality and cope with the increased workload associated with chronic
diseases [17]. There are clear benefits conferred by COC; from the perspective of economic the-
ory, a greater number of choices may increase the likelihood of matching patients to the most
appropriate providers. Competition between providers could also improve the quality of ser-
vices from the patient’s perspective [18]. The Korean system is markedly different from the
managed care delivery of the United States, in which the patient’s choice of health care provider
is regulated and restricted [19]. All Korean hospitals can provide outpatient services, and there
are no barriers to using superior health services and patients can select health care providers
without limitations. Moreover, all health care providers in South Korea are in competition. In
the case of South Korea, NHI is the single insurer that manages the NHI program and the costs
of medical service; hence health care providers do not compete in the perspective of cost but in
the perspectives of providing amenities, friendly service, and detailed explaining in order to
attract more patients. Thus Individual’s freedom of choice may improve quality of care[20].
However, in contrast this may cut off continuous care in the perspective of information flow
and the relationship between health care providers and patients. This reduction in the continu-
ity of care may lead to undesirable outcomes.
This study assessed the effect of competition among health care providers with regard to
COC, and determined the association between COC and hospital admissions in asthmatic
children.
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Methods
Data sources
This study used three data sources. The first source was the National Health Insurance claims
data of asthmatic children, obtained from the Health Insurance Review and Assessment
(HIRA) between 2009 and 2013. This sample data are representative of the country as a whole,
and is stratified according to sex, age (grouped according to 5-year intervals), and outpatient/
inpatient diseases status. Information on 23,909 patients (approximately 1% of all Korean
asthma patients) was available, including full medical histories between 2009 and 2013, age,
sex, costs of care, prescription history, diagnostic test results, and several other parameters. The
National Health Insurance Corporation represented the second source of data, and was used to
calculate market concentration; this population data, for respiratory diseases between 2002 and
2012, did not include information pertaining to prescription history or diagnostic test results.
The third data source was the Korean Statistical Information Service, which was used to gather
information on regional health care providers. Ethical approval for this study was granted by
the institutional review board of the Graduate School of Public Health, Yonsei University,
Seoul, Korea. This study was retrospective research, and our data was not including personal
information. So we could not obtain consent. As consent was not obtained, patient records and
information was anonymized and de-identified prior to analysis.
Study population
Data for 23,909 asthmatic patients were available for 2009. Of these, we excluded 13,912
patients: 13,372 patients were>13 years of age, 2 patients did not possess health insurance or
medical aid (other health securities were in place, e.g., veteran-specific security), and 538
patients with a main diagnosis of J45 were not prescribed asthma medication, had taken no test
for asthma, and made only 1 outpatient visit during the year.
We defined medical usage as cases in which patients visited an outpatient clinic, received a
main diagnosis of J45, and received a prescription for 1 asthma medication [21]. We
excluded 538 asthma patients who made only 1 outpatient visit during the year and were not
prescribed asthma medication. However, regardless of the number of outpatient visits, if the
patient had undergone a test of IgE blood levels or multiple radioallergosorbent tests (MAST),
they were eligible for inclusion. The rationale for this criterion was to improve the accuracy of
asthma diagnoses, which were based on information obtained from the insurance claims data-
base. Diagnosis accuracy using Korean claims data are approximately 70% [22]. Therefore, an
additional criterion was required to ensure that all of the included participants were actually
asthmatic; frequent asthma-related visits were used for this purpose, rendering a final study
sample of 9,997 (Fig 1).
Variables
The dependent variable was hospital admissions due to asthma, defined as using inpatient
medical services for>1 day and receiving a main diagnosis of J45.
Between 2009 and 2013, we measured COC for each patient using the Usual Provider Conti-
nuity (UPC) index [23]. Three indices are commonly used to measure COC: the COC index,
the Sequential Continuity of Care (SECON) index, and the UPC index. We selected the UPC
index because it was the instrument most capable of identifying the association between market
competition and COC. This index describes the proportion of visits made to the patient’s regu-
lar physician out of all visits. According to the literature, if no regular physician is assigned to a
patient, the index is computed so that the physician that the patient visited most frequently
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during the defined time period is assigned as the patient’s regular physician. The index ranges
between 0 and 1, with higher values indicating superior COC. The formula for the UPC index
is as follows:
UPC ¼ 1  j  MðnjÞ
N
N is the total number of ambulatory care visits, nj is the number of visits to the jth provider with
whom the patient made the greatest number of visits, andM is the number of potentially avail-
able providers. In this study, potentially available providers refer to healthcare institutions and
not to medical physicians. We arbitrarily categorized this into three groups: four or more ambu-
latory visits and a UPC index rating above mean, four or more ambulatory visits and a UPC
index below the mean, and three or below ambulatory visits. We included in the study
Fig 1. Flowchart of study participant selection. *, The National Health Insurance claims data consisted of 4 tables (20, 30, 40, and 53 table). Each table
includes different information. †, MAST; multiple radioallergosorbent test.
doi:10.1371/journal.pone.0150926.g001
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population subjects whose primary diagnosis was asthma and had a record of being prescribed
with asthma medications. Regardless of ambulatory visits, we included only identiﬁed patients
whose primary diagnosis was asthma and tested by related asthma diagnostic tests. In fact, we
made an effort to identify real asthmatic children as in the case of children, even if a child makes
only one ambulatory visit per year, he or she is likely to be a patient with asthma. In addition,
although asthma is one of the ambulatory care-sensitive conditions (ACSCs), asthma shares
many similar characteristics with other chronic diseases such as diabetes, hypertension and
chronic obstructive pulmonary disease which is controlled through daily medication. Hence the
total number of visits due to asthmatic symptoms, which can generally be controlled through
medication, may indicate the severity of the disease itself; increased ambulatory visits can thus
mean that the disease is severe. Therefore, we divided based on whether the number of ambula-
tory visits equaled or exceeded four, and then further divided depending on whether the UPC
index score scored above the mean score of the group with four or more ambulatory visits.
We measured market competition among health care providers using the Herfindahl–
Hirschman Index (HHI). To calculate the HHI, we distinguished hospital markets according to
253 administrative districts within Korea. The equation for HHI is as follows:
Herf indahlHirschman Index ðHHIÞ ¼
Xn
i ¼ 0
S2i
The HHI is the sum of squared market shares for hospitals within a market. Market share (Si)
is computed using total charges for patients with respiratory diseases excluding lung cancer; i
denotes an individual hospital, and n is the total number of hospitals in the market. A low HHI
indicates the presence of less-dominant hospitals or greater competition in that particular mar-
ket. Conversely, a high HHI indicates the presence of dominant hospitals or reduced competition
[24,25]. To examine the relationship between market competition and hospital admission rate,
we divided HHI into four categories. The total of number of patient visits was 8,202,548,109 for
outpatient clinics (it is probable for one individual to utilize the facilities multiple times) nation-
wide during 2009 for respiratory-related diseases, excluding lung cancer, with a total of 17,029
outpatient clinics included in the HHI analysis. Community clinics were included in 17,029 out-
patient clinics because community clinics shared a substantial number of patients in small areas.
Covariates
Covariates comprised both individual and regional variables. Individual variables included age,
sex, insurance type (e.g., health insurance, medical aid), Charlson Comorbidity Index (CCI)
score (0–3+), type of main visiting medical institution (general or tertiary hospital, hospital,
clinic, public health center), total ambulatory care visits (1–4+), use of inhaled corticosteroid,
and presence of respiratory distress. We used three proxy variables: the CCI score of patient
severity, presence of respiratory distress, and total ambulatory care visits. For the CCI, only the
comorbidity component was calculated [26]. All diagnostic information was collected using
inpatient and outpatient billing data for each year. Respiratory distress was defined as a main
diagnosis of J45, with R06 (on the ICD-10) as an additional diagnosis. The type of main visiting
institution was the healthcare institution visited most frequently for outpatient care. Regional
variables included inpatient beds per 1,000 population, total number of hospitals, physicians
per 1,000 population, and HHI. Regional variables were categorized according to administra-
tive district; Si and Do (metropolitan and state; n = 16); and Si, Gun, and Gu (city, county, and
ward; n = 253). Each Si and Do has elements of Si, Gun, and Gu. We measured regional vari-
ables at the Si, Gun, and Gu levels. We repeatedly measured all individual and regional vari-
ables between 2009 and 2013.
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Statistical analysis
We initially conducted a descriptive study analyzing baseline (2009) frequencies and means.
To identify the association between market competition and COC, and to allow for non-inde-
pendence between study subjects clustered within districts, we fitted a random intercept model
using a longitudinal technique and taking time-invariant characteristics into account. To assess
the association between COC and hospital admissions, we fitted a random intercept logistic
regression model, adjusted for individual and regional level variables. Since our study sample
has a nested data structure where individual levels are clustered within higher-level regions,
hierarchical linear modeling is used to examine the relationships between hospital admission
and its covariates. Two-level random effects models are fitted using the maximum likelihood
estimation (MLE), in order to capture associations between individual and regional level mea-
sures and the dependent variable. The basic model for the multilevel analysis is represented by
the following equation:
Yij ¼ b0 þ b1Rij þ b2Rj þ b3Xij þ mj þ εij
Yij refers to hospital admission for individual I (Level 1) in region j (Level 2), Rij the set of
main independent variables measured at Level 1, Rj the Level-2 variables, and X the vectorfor
control variables. The β’s are fixed parameters to be estimated, μj the region-specific random
effect, and εij a component of the error term (Raudenbush and Bryk, 2002). All statistical anal-
yses were performed using the SAS statistical software package (ver. 9.3, SAS Institute, Cary,
NC, USA).
Results
General characteristics
Table 1 describes the characteristics of study subjects and regions at baseline (n = 9,997). A
high proportion (54%) of the patients was between 0 and 3 years of age; 57.3% of the patients
were males, and 97% were National Health Insurance beneficiaries. In total, 29.4% of patients
had a existence comorbidity; 11.1% used an inhaled corticosteroids, and 5.5% exhibited respi-
ratory distress. Of all the children in the sample, 85.7% frequently used the clinic. The mean
HHI of the 253 districts including 17,029 hospitals was 1959.5 (standard deviation (SD), 47.7),
the mean of number of beds per 1000 population 11.3 (SD, 6.8), the mean of number of doctors
per 1000 population 2.3 (SD, 2.0), and the mean of total outpatient health care provider 70.9
(SD, 47.7). Table 2 presents COC distributions and hospital admissions by year. The propor-
tion of hospital admissions ranged between 0.7% and 2.4% and decreased across years; in the
group making more than two visits, 55.1% of patients visited a single health care provider or
institution in 2009 compared to 14.7% in 2013.
The association between individual and regional variables and COC
(UPC index)
Table 3 presents the regression coefficient estimates from the multilevel models. After adjusting
for all individual variables which include age, sex, health insurance type, residential area, exis-
tence comorbidity, respiratory distress, the use of inhaled corticosteroid, and the main type of
attending clinic, and all regional variables which include HHI, the number of beds per 1000
population, the number of doctors per 1000 people, and total outpatient health care provider,
when HHI increased by 100,000 points, UPC index scores were also found to increase (ß =
0.11, p< 0.0001). This indicates that the COC of children living in areas with less market com-
petition was higher. With increasing numbers of doctors per 1,000,000 population, UPC index
The Effect of Market Competition on COC and Hospitalization
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Table 1. Baseline characteristics of study subjects.
Characteristics Study subjects (N = 9,997)
Individual variables
Age (y), n (%)
0–3 5,458 (54.6)
4–6 3,182 (31.8)
7–9 814 (8.1)
10–12 543 (5.4)
Sex, n (%)
Male 5,732 (57.3)
Female 4,265 (42.7)
Health insurance type, n (%)
National health insurance 9,701 (97.0)
Medical aid 296 (3.0)
Residential area
Urban 9,462 (94.7)
Rural 535 (5.4)
The other diseases, n (%)
No 7,054 (70.6)
Yes 2,943 (29.4)
Respiratory distress
Yes 550 (5.5)
No 9,447 (94.5)
Use of inhaled corticosteroid
Yes 1,112 (11.1)
No 8,885 (88.9)
Number of total visits
1 5,279 (52.8)
2 809 (8.1)
3 649 (6.5)
 4 3,260 (32.6)
Main type of attending clinic
Tertiary general hospital 190 (1.9)
General hospital 591 (5.9)
Hospital 649 (6.5)
Clinic 8,567 (85.7)
Regional variables*
HHI†, mean (SD) 1959.5(47.7)
Number of beds per 1,000 population 11.3(6.8)
Number of doctors per 1,000 population 2.3(2.0)
Total outpatient health care provider 70.9(47.7)
*, measuring regional variables in 253 administrative districts according to geographical boundaries at the
Si, Gun, and Gu (city, county, ward) levels.
†, HHI, Herﬁndahl–Hirschman Index; A low HHI score indicates the presence of less-dominant hospitals, or
more competition in that particular market.
doi:10.1371/journal.pone.0150926.t001
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scores also decreased (ß = -0.21, p< 0.05). In addition, because of the distribution of UPC and
HHI scores, we analyzed using log transformation of UPC and HHI scores, and we presented
the results before and after the log transformation.
Factors associated with hospital admission
Table 4 describes the association between individual characteristics and hospital admissions
after controlling for all regional variables which include age, sex, health insurance type, resi-
dential area, existence comorbidity, respiratory distress, the use of inhaled corticosteroid, and
the main type of attending clinic, and all regional variables which include HHI, the number of
beds per 1000 population, the number of doctors per 1000 population and the total outpatient
health care provider, evaluated using multilevel logistic regression. The adjusted odds ratio
(OR) for children between 0–2 years of age, relative to the reference group (10–12 years of age)
was 1.55 (95% CI: 1.15, 2.10). Children who exhibited respiratory distress or were using inhaled
corticosteroids were characterized by a higher OR compared to those who did not use cortico-
steroids (OR, 2.46; 95% CI: 1.77–3.42; and OR, 2.23; 95% CI: 1.84–2.72, respectively). The
adjusted OR was 2.72 (95% CI: 2.14–3.46) for those visiting the ambulatory clinic on more
than four occasions and with a UPC index with below mean compared to the reference group
Table 2. Continuity of care and hospital admissions, by year.
Study subjects (N = 9,997)
2009 2010 2011 2012 2013
UPC index* (mean, SD) 0.82 (0.14) 0.83 (0.14) 0.85 (0.13) 0.85(0.12) 0.86 (0.11)
Continuity of care, n (%)
 4 visits and UPC index (above mean) 4,092 (40.9) 3265 (32.7) 3,369 (33.7) 1,673 (16.7) 927 (9.3)
 4 visits and UPC index (below mean) 655 (6.6) 486 (4.9) 445 (4.5) 213 (2.1) 114 (1.1)
 3 visit 5,293 (52.5) 6,246 (62.5) 6,183 (61.8) 8,111 (81.1) 8,956 (89.6)
Hospital admission, n (%)
Yes 243.4) 175 (1.8) 67 (1.7) 69 (0.7) 33 (0.4)
No 9,754 (97.6) 9,797 (98.2) 9,805 (98.3) 9,903 (99.3) 9,939 (99.6)
*, the index ranges between 0–1; a higher value corresponds to improved continuity of care.
doi:10.1371/journal.pone.0150926.t002
Table 3. Multilevel regression analysis: the associations between HHI and UPC scores (N = 9,997).
Adjusted† UPC Index Ln (UPC index)
Adjusted ß† (SE) Adjusted ß†, (SE)
HHI increase by 100,000 points 0.11 0.03 0.22*** 0.37‡ -0.12 0.45
Total number of hospitals per 100,000 population 0.03 -0.01 0.05 0.06 -0.18 0.06
Number of beds per 1,000,000 population 0.23 -0.06 0.08 0.11 -0.92 1.14
Number of doctors per 1,000,000 population -0.21 -0.45 -0.04* -0.29 -0.56 -0.16*
HHI, Herﬁndahl–Hirschman Index; SE, standard error.
*p < 0.05.
***p < 0.0001.
†, full model; adjusted for all individual and regional variables.
‡, coefﬁcient for Ln (HHI scores).
doi:10.1371/journal.pone.0150926.t003
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Table 4. ORs and 95%CIs for hospital admissions: results of multi-level logistic regressionmodels (N = 9,997).
Model 1* Model 2*
OR 95% CI OR 95% CI
Individual-level variables
Age (y; ref. 10–12)
0–2 1.53 (1.14–2.06) 1.55 (1.15–2.10)
3–5 0.90 (0.67–1.21) 0.91 (0.68–1.22)
6–9 0.86 (0.63–1.16) 0.87 (0.64–1.18)
Sex (ref. Male)
Female 0.77 (0.65–0.92) 0.77 (0.65–0.91)
Health insurance type (ref. National health insurance)
Medical aid 1.69 (1.14–2.49) 1.67 (1.13–2.46)
Residential area (ref. Rural)
Urban 1.06 (0.64–1.78) 1.20 (0.69–2.08)
The other diseases (ref. No)
Yes 2.42 (1.74–3.36) 2.46 (1.77–3.42)
Respiratory distress (ref. No)
Yes 3.75 (2.99–4.69) 3.80 (3.03–4.76)
Use of inhaled corticosteroid (ref. No)
Yes 2.24 (1.84–2.72) 2.23 (1.84–2.72)
Total number of visits (ref. 1)
2 0.81 (0.58–1.13) 0.81 (0.58–1.13)
3 0.84 (0.58–1.20) 0.83 (0.58–1.20)
 4 1.15 (0.93–1.43) 1.15 (0.92–1.43)
Main clinic type attended (ref. Clinic)
Tertiary general hospital 6.50 (4.57–9.23) 6.57 (4.60–9.38)
General hospital 7.22 (5.73–9.09) 7.20 (5.72–9.07)
Hospital 4.00 (3.06–5.24) 3.96 (3.03–5.19)
Continuity of care (ref.  4 visits and UPC index with above mean)
 4 visits and UPC index with below mean 2.66 (2.09–3.39) 2.72 (2.14–3.46)
 3 visit 0.69 (0.59–0.99) 0.69 (0.57–0.84)
Region-level variables
HHI (ref. Quartile 1)
Quartile 2 1.41 (1.02–1.94)
Quartile 3 1.08 (0.74–1.57)
Quartile 4 0.97 (0.63–1.49)
Number of hospitals per 1,000 population (ref. Quartile 1)
Quartile 2 0.90 (0.65–1.25)
Quartile 3 0.84 (0.58–1.23)
Quartile 4 0.70 (0.45–1.07)
Number of bed per 1,000 population (ref. Quartile 1)
Quartile 2 1.14 (0.81–1.60)
Quartile 3 1.79 (1.24–2.59)
Quartile 4 1.69 (1.13–2.52)
Number of doctors per 1,000 population (ref. 1)
2 0.90 (0.60–1.34)
3 0.95 (0.57–1.56)
4 0.94 (0.51–1.71)
*, In Model 1, results were adjusted for all individual variables; in Model 2, results were adjusted for all individual and regional variables.
doi:10.1371/journal.pone.0150926.t004
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( 4 ambulatory visits and a UPC index with above mean). The adjusted HHI OR for children
residing in quartile 2 was 1.41(95% CI, 1.02–1.94), relative to the HHI values of those in quar-
tile 1. Increases in the number of beds per 1000 population were associated with increased
ORs. The adjusted OR for quartile 3 of the number of bed per 1000 population was 1.79 (95%
CI, 1.24–2.59), and the adjusted OR for quartile 4 was 1.69 (95% CI, 1.13–2.52), relative to the
reference group (quartile 1).
Discussion
We examined the relationship between market competition and COC, and assessed the effect
of COC on hospital admissions in asthmatic children. Children living in less competitive areas
were characterized by a higher UPC index; those with a UPC index score of 1 exhibited a lower
OR for hospital admission. The ORs of children visiting more than one health care provider or
institution was 3.61-fold higher compared to those who visited only one health care provider
or institution.
The COC of children living in more competitive areas was lower; a low COC was associated
with a higher OR for hospital admission. At the same time, the adjusted odds ratio of hospital
admission for groups in quartile 1 regarding HHI was greater relative to the group in quartile 2
regarding HHI. Namely, the odds ratio for hospital admission may be the higher when the
level of competition is lower. Korea’s health care market lies on competition among health care
providers. This relates to health care delivery system, which is organized as follows: clinics
function as primary care institutions, hospitals functions as secondary care institutions, and
general hospitals and tertiary general hospitals function as tertiary care institutions [27]. As
mentioned above, all of these institutions can provide outpatient services with no barriers to
the use of superior health services. Furthermore, in Korea, 91% of clinical physicians are spe-
cialists, and 98% of clinics were the sole practice used during 2006 [28]. Many previous studies
have shown that higher market competition may improve quality of care as a whole [20]. How-
ever, when concerning individual aspects, patients had more opportunity to select healthcare
providers and was able to more easily access suitably qualified physicians when higher levels of
competition was present among health care providers and patients had more freedom in select-
ing health care providers. Moreover, unalike adult patients, if the symptoms of asthmatic chil-
dren did not improve speedily, parents were willing to seek a different health care provider.
These circumstances including high market competition may lead to a reduction in the conti-
nuity of care and there may be disadvantages in the management of patient information. As a
result, children with low COC may be likely to admitted.
Our data indicate that superior COC is associated with improved health outcomes, which is
consistent with previous studies. However, we could not identify the mechanism underlying
this association. Gray et al. (2003) suggested that COC could benefit patients by reinforcing the
accumulation of patient knowledge, improving interpersonal communication, and increasing
the likelihood that patients adhere to their doctor’s advice. In addition, our findings reveal that
higher number of hospitals per 1000 population is also associated with higher UPC but that
higher numbers of physician per 1000 population is associated with lower UPC scores. The fea-
ture shared by most small areas is that there is a lack of general hospitals and tertiary hospitals
with a sufficient number of physicians. In fact, even if a certain district has many hospitals, if
all of these hospitals are institutions that provide medical services through one physician, the
district will be score high in the total number of hospitals per 1,000 population but will score
low in the number of doctors per 1,000 population. In contrast, if a certain district has few hos-
pitals but several of these hospitals are general hospitals or tertiary hospitals, the district will
score low in the total number of hospitals per 1000 population and will score high in the
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number of doctors per 1000 population. Therefore, the total number of hospitals and number
of doctors per 1000 population depends on the composition of general hospitals, which include
many physicians and clinics operated solely by one physician. Differences in this composition
in each district may lead to the shown results.
Patients receiving care at general/tertiary hospitals were more likely to be admitted than
those treated at clinics. Although we attempted to adjust case complexity and disease severity
according to respiratory distress status and CCI scores, our data appear to reflect the fact that
disease severity is greater in patients using higher-level hospitals. Although several previous
studies reported that the use of inhaled corticosteroid is associated with a reduced likelihood of
hospital admission and use of emergency medical services [29–31], our data indicated the oppo-
site. The majority of our sample principally used clinics for outpatient care. In October 2010,
the Korean incentive system for outpatient, drug-focused clinics was introduced to reduce drug
and prescription costs [32]. Inhaled corticosteroids are more expensive compared to oral corti-
costeroids; physicians are therefore more likely to prescribe oral corticosteroids, and only to
children with severe asthma. This situation may have influenced our equivocal result.
This study had several limitations. First, with regard to the accuracy of the asthma diagnosis,
we used the National Health Insurance claims database from HIRA. The claimed data are sent
to HIRA, which reviews the claims for reimbursement. The compulsory nature of the Korean
NHI system (established in 1989) means that the system provides universal coverage. It was
one of the earliest adaptive organizations to exercise leadership in information technology (IT)
among public institutions by strengthening and providing coverage using the latest IT[33].
However, this can serve as limitations in the use of these databases. These data do not include
uninsured events and only represent services covered by the NHI. The data may not be consis-
tent with actual diagnosis because it is ordinarily made for claiming purposes. Diagnostic accu-
racy in KNHI claims data are approximately 70%[34]; to increase accuracy, we reviewed all
prescriptions and diagnostic tests, but 100% accuracy could nonetheless not be guaranteed. In
addition, 94.5% of the subjects had no respiratory distress. We defined respiratory distress as
having an ICD-10 code of R06. R06.0 is dyspnea, R06.1 is stridor, and R06.2 is wheezing.
When physicians conducted physical examinations, respiratory distress might not have been
present or physicians may not have conducted coding. This phenomenon may lead act as a lim-
itation of claims data. Second, we could not consider all factors that might affect the association
between UPC index scores and hospital admissions, such as income level, education, physician
characteristics, and general health behaviors, because this information was not present in the
claims database. Third, we could not assess the quality of outpatient clinics according to the
degree of market competition. Finally, we could not identify individual service providers on the
basis of information extracted from the claims database. Therefore, outpatient healthcare pro-
viders were medical institutions rather than physicians.
Despite these limitations, our study also had several strengths. First, we analyzed a represen-
tative sample of asthma patients using nationwide claims data and a longitudinal design. In
addition, we adjusted for disease severity by recording respiratory distress status and including
prescription of asthma medication as a criterion of ambulatory care. Finally, we considered
both individual and regional variables that may be associated with COC and hospital admis-
sion rates.
While market competition may help improve quality of care, it may also induce patients’
discontinuity of care. Especially, these phenomena get worse in countries like Korea, which
provide universal health insurance coverage, and where all health care providers compete with
one another and patients can select any health care institution without certain regulation such
as gatekeeper. Therefore, we need to reform health care delivery system to prevent unnecessary
hospitalization and reduce costs due to discontinuity. Also, market competition should be
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managed while improving quality of care through an accountable care organization (ACO),
which accepts financial responsibility, care accountability and at the same time increases value
in the health care system by reducing cost without worsening quality [35].
In conclusion, our results support the hypothesis that improving COC can reduce hospital
admission risk in asthmatic patients. We encourage policymakers to recognize the need for an
effective healthcare delivery system promoting COC, by encouraging a collaborative approach,
enhancing accessibility, and considering the impact of market competition.
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